Chloë Shaw-Jackson1, Mélissa Capraro2, Lieveke Ameye3, Jean Vandromme2, Yannick Manigart2, Serge Rozenberg2, Candice Autin2. 1. Department of Gynaecology, CHU St-Pierre, Université Libre de Bruxelles, Rue Haute 322, 1000, Brussels, Belgium. Chloe_shaw-jackson@stpierre-bru.be. 2. Department of Gynaecology, CHU St-Pierre, Université Libre de Bruxelles, Rue Haute 322, 1000, Brussels, Belgium. 3. Data centre, Jules Bordet Institute Université Libre de Bruxelles, Rue Hégèr Bordet 1, 1000, Brussels, Belgium.
Abstract
PURPOSE: The aim of this study was to investigate whether infection of women by the hepatitis C virus (HCV) reduces the chance of conceiving after in vitro fertilization (IVF). METHODS: We performed a retrospective blind matched case-control study where IVF outcomes for the first 37 cycles of HCV sero-positive women were compared to those of 107 cycles of an uninfected control group. Our results were included in a systematic literature review. RESULTS: Out of five eligible studies, ours included, three observed an impact of HCV infection, though at various levels including response to stimulation, fertilization, implantation, and pregnancy rates. Two studies differentiated results for patients with confirmed active viral replication. Matching criteria and populations studied varied between studies. CONCLUSIONS: More and larger studies with well-defined groups are needed to clarify the eventual impact of the HCV on IVF outcomes. Data concerning the infectious status of a patient as well as her health state should be systematically recorded. A multi-disciplinary approach as well as a thorough knowledge of the patient's general health state might prove useful in the management and counseling of these patients in terms of success in conceiving.
PURPOSE: The aim of this study was to investigate whether infection of women by the hepatitis C virus (HCV) reduces the chance of conceiving after in vitro fertilization (IVF). METHODS: We performed a retrospective blind matched case-control study where IVF outcomes for the first 37 cycles of HCV sero-positive women were compared to those of 107 cycles of an uninfected control group. Our results were included in a systematic literature review. RESULTS: Out of five eligible studies, ours included, three observed an impact of HCV infection, though at various levels including response to stimulation, fertilization, implantation, and pregnancy rates. Two studies differentiated results for patients with confirmed active viral replication. Matching criteria and populations studied varied between studies. CONCLUSIONS: More and larger studies with well-defined groups are needed to clarify the eventual impact of the HCV on IVF outcomes. Data concerning the infectious status of a patient as well as her health state should be systematically recorded. A multi-disciplinary approach as well as a thorough knowledge of the patient's general health state might prove useful in the management and counseling of these patients in terms of success in conceiving.
Entities:
Keywords:
HCV; Hepatitis C virus; IVF; Implantation; In vitro fertilization; Systematic review
Authors: C Pasquier; M Daudin; L Righi; L Berges; L Thauvin; A Berrebi; P Massip; J Puel; L Bujan; J Izopet Journal: AIDS Date: 2000-09-29 Impact factor: 4.177
Authors: A Devaux; V Soula; C Sifer; M Branger; M Naouri; R Porcher; C Poncelet; A Neuraz; S Alvarez; J L Benifla; P Madelenat; F Brun-Vezinet; G Feldmann Journal: Hum Reprod Date: 2003-11 Impact factor: 6.918
Authors: Aaron D Blackwell; Marilyne A Tamayo; Bret Beheim; Benjamin C Trumble; Jonathan Stieglitz; Paul L Hooper; Melanie Martin; Hillard Kaplan; Michael Gurven Journal: Science Date: 2015-11-20 Impact factor: 47.728
Authors: Jordan J Feld; Ira M Jacobson; Christophe Hézode; Tarik Asselah; Peter J Ruane; Norbert Gruener; Armand Abergel; Alessandra Mangia; Ching-Lung Lai; Henry L Y Chan; Francesco Mazzotta; Christophe Moreno; Eric Yoshida; Stephen D Shafran; William J Towner; Tram T Tran; John McNally; Anu Osinusi; Evguenia Svarovskaia; Yanni Zhu; Diana M Brainard; John G McHutchison; Kosh Agarwal; Stefan Zeuzem Journal: N Engl J Med Date: 2015-11-16 Impact factor: 91.245